Skip to main content
Erschienen in: Skeletal Radiology 4/2017

11.02.2017 | Scientific Article

Characterisation of musculoskeletal tumours by multivoxel proton MR spectroscopy

verfasst von: Ruchi S. Patni, Deb K. Boruah, Shantiranjan Sanyal, Bidyut B. Gogoi, Maninder Patni, Rosy Khandelia, Nripen Gogoi

Erschienen in: Skeletal Radiology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

The purpose of this study is to evaluate the role of multi-voxel proton MR spectroscopy in differentiating benign and malignant musculoskeletal tumours in a more objective way and to correlate the MRS data parameters with histopathology.

Methods and materials

A hospital-based prospective study was carried out comprising 42 patients who underwent MRI examinations from 1 July 2013 to 30 June 2014. After routine sequences, single-slice multi-voxel proton MR spectroscopy was included at TE-135 using the PRESS sequence. The voxel with the maximum choline/Cr ratio was used for analysis of data in 32 patients. The strength of association between the MR spectroscopy findings and the nature of tumour and histopathological grading were assessed.

Results

Of the 42 patients, the MR spectra were not of diagnostic quality in 10. In the remaining 32 patients, 12 (37.5%) had benign and 20 (62.5%) malignant tumours. The mean choline/Cr ratio was 6.97 ± 5.95 (SD) for benign tumours and 25.39 ± 17.72 (SD) for malignant tumours. In our study statistical significance was noted between the choline/Cr ratio and the histological nature of musculoskeletal tumours (p = 0.002) assessed by unpaired t-test. The choline/Cr ratio and histological grading were also found to be significant (p = 0.001) when assessed by one-way ANOVA test.

Conclusions

Multi-voxel MR spectroscopy showed a higher choline/Cr ratio in malignant musculoskeletal tumours than in benign ones (p = 0.002). The choline/Cr ratio and histological grading of musculoskeletal tumours also showed statistical significance (p = 0.001).
Literatur
1.
Zurück zum Zitat Stark DD, Bradley WG. Magnetic Resonance Imaging, 2nd ed. St. Louis Mosby-Year Book 1992. Stark DD, Bradley WG. Magnetic Resonance Imaging, 2nd ed. St. Louis Mosby-Year Book 1992.
2.
Zurück zum Zitat Wang CK, Hsieh TJ, Jaw TS, Lin JN, Liu GC, Li CW. Clinical application of in vivo proton (1H) MR spectroscopy. Spectroscopy. 2005;19:181–90.CrossRef Wang CK, Hsieh TJ, Jaw TS, Lin JN, Liu GC, Li CW. Clinical application of in vivo proton (1H) MR spectroscopy. Spectroscopy. 2005;19:181–90.CrossRef
3.
Zurück zum Zitat Rosenberg AE. Chapter 26- Bones, Joints, and Soft Tissue Tumours, Kumar V, Abbas AK, and Fausto N, Robbin and Cotran Pathologic Basis of Disease, 7th edition, Elsevier Inc. India; 2004:1273-1324. Rosenberg AE. Chapter 26- Bones, Joints, and Soft Tissue Tumours, Kumar V, Abbas AK, and Fausto N, Robbin and Cotran Pathologic Basis of Disease, 7th edition, Elsevier Inc. India; 2004:1273-1324.
4.
Zurück zum Zitat Daniel Jr A, Ullah E, Wahab S, Kumar Jr V. Relevance of MRI in prediction of malignancy of musculoskeletal system—A prospective evaluation. BMC Musculoskelet Disord. 2009;10:125.CrossRefPubMed Daniel Jr A, Ullah E, Wahab S, Kumar Jr V. Relevance of MRI in prediction of malignancy of musculoskeletal system—A prospective evaluation. BMC Musculoskelet Disord. 2009;10:125.CrossRefPubMed
5.
Zurück zum Zitat Hermann G, Abdel Wahab IF, Miller TT, Klein MJ, Lewis MM. Tumour and tumour-like conditions of the soft tissue: magnetic resonance imaging features differentiating benign from malignant masses. Br J Radiol. 1992;65(769):14–20.CrossRefPubMed Hermann G, Abdel Wahab IF, Miller TT, Klein MJ, Lewis MM. Tumour and tumour-like conditions of the soft tissue: magnetic resonance imaging features differentiating benign from malignant masses. Br J Radiol. 1992;65(769):14–20.CrossRefPubMed
6.
Zurück zum Zitat Alyas F, James SL, Davies AM, Saifuddin A. The role of MR imaging in the diagnostic characterisation of appendicular bone tumours and tumour-like conditions. Eur Radiol. 2007;17(10):2675–86.CrossRefPubMed Alyas F, James SL, Davies AM, Saifuddin A. The role of MR imaging in the diagnostic characterisation of appendicular bone tumours and tumour-like conditions. Eur Radiol. 2007;17(10):2675–86.CrossRefPubMed
7.
Zurück zum Zitat Sah PL, Sharma R, Kandpal H, Seith A, Rastogi S, Bandhu S, et al. In vivo proton spectroscopy of giant cell tumor of the bone. Am J Roentgenol. 2008;190:433.CrossRef Sah PL, Sharma R, Kandpal H, Seith A, Rastogi S, Bandhu S, et al. In vivo proton spectroscopy of giant cell tumor of the bone. Am J Roentgenol. 2008;190:433.CrossRef
8.
Zurück zum Zitat Van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2010;39:527–40.CrossRefPubMed Van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2010;39:527–40.CrossRefPubMed
9.
Zurück zum Zitat Wang CK, Li CW, Hsieh TJ, Chien SH, Liu GC, Tsai KB. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology. 2004;232:599–605.CrossRefPubMed Wang CK, Li CW, Hsieh TJ, Chien SH, Liu GC, Tsai KB. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology. 2004;232:599–605.CrossRefPubMed
10.
Zurück zum Zitat Subhawong TK, Wang X, Durand DJ, Jacobs MA, Carrino JA, Machado AJ, et al. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. Am J Roentgenol. 2012;198:162–72.CrossRef Subhawong TK, Wang X, Durand DJ, Jacobs MA, Carrino JA, Machado AJ, et al. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. Am J Roentgenol. 2012;198:162–72.CrossRef
11.
Zurück zum Zitat Fayad LM, Wang X, Salibi N, Barker PB, Jacobs MA, Machado AJ, et al. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. Am J Roentgenol. 2010;195:207.CrossRef Fayad LM, Wang X, Salibi N, Barker PB, Jacobs MA, Machado AJ, et al. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T. Am J Roentgenol. 2010;195:207.CrossRef
12.
Zurück zum Zitat Marks KE, Belhobek GH. Chapter 10. Tumours of the Musculoskeletal System. Robert B Duthie & George Bently. Mercer’s Orthopaedic Surgery, 9th ed. Jaypee Brothers. India, 2003;653-676. Marks KE, Belhobek GH. Chapter 10. Tumours of the Musculoskeletal System. Robert B Duthie & George Bently. Mercer’s Orthopaedic Surgery, 9th ed. Jaypee Brothers. India, 2003;653-676.
13.
Zurück zum Zitat Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devessa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer. 2006;119(12):2922–30.CrossRefPubMed Toro JR, Travis LB, Wu HJ, Zhu K, Fletcher CD, Devessa SS. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer. 2006;119(12):2922–30.CrossRefPubMed
14.
Zurück zum Zitat Murphey MD, Nomikos GC, Flemming DJ, Gan-non FH, Temple HT, Kransdorf MJ. From the Archives of the AFIP: Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. RadioGraphics. 2001;21(5):1283–309.CrossRefPubMed Murphey MD, Nomikos GC, Flemming DJ, Gan-non FH, Temple HT, Kransdorf MJ. From the Archives of the AFIP: Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologic-pathologic correlation. RadioGraphics. 2001;21(5):1283–309.CrossRefPubMed
15.
Zurück zum Zitat Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol. 2003;24:1989–98.PubMed Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. Am J Neuroradiol. 2003;24:1989–98.PubMed
16.
Zurück zum Zitat Bartella L, Morris EA, Dershaw DD, Liberman L, Thakur SB, Moskowitz C, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology. 2006;239:686–92.CrossRefPubMed Bartella L, Morris EA, Dershaw DD, Liberman L, Thakur SB, Moskowitz C, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology. 2006;239:686–92.CrossRefPubMed
17.
18.
Zurück zum Zitat Mountford C, Lean C, Malycha P, Russell P. Proton spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imaging. 2006;24:459–77.CrossRefPubMed Mountford C, Lean C, Malycha P, Russell P. Proton spectroscopy provides accurate pathology on biopsy and in vivo. J Magn Reson Imaging. 2006;24:459–77.CrossRefPubMed
19.
Zurück zum Zitat Ackerstaff E, Glunde K, Bhujwalla ZM. Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem. 2003;90:525–33.CrossRefPubMed Ackerstaff E, Glunde K, Bhujwalla ZM. Choline phospholipid metabolism: a target in cancer cells? J Cell Biochem. 2003;90:525–33.CrossRefPubMed
20.
Zurück zum Zitat Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992;5:226–33.CrossRefPubMed Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed. 1992;5:226–33.CrossRefPubMed
21.
Zurück zum Zitat Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 2005;234:804–14.CrossRefPubMed Zakian KL, Sircar K, Hricak H, Chen HN, Shukla-Dave A, Eberhardt S, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology. 2005;234:804–14.CrossRefPubMed
22.
Zurück zum Zitat Mullins ME. MR spectroscopy: truly molecular imaging—past, present and future. Neuroimaging Clin N Am. 2006;16:605–18.CrossRefPubMed Mullins ME. MR spectroscopy: truly molecular imaging—past, present and future. Neuroimaging Clin N Am. 2006;16:605–18.CrossRefPubMed
23.
Zurück zum Zitat Meisamy S, Bolan PJ, Baker EH, Bliss RL, Gulbahce E, Everson LI, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in-vivo 1H MR spectroscopy—a pilot study at 4T. Radiology. 2004;233:424–31.CrossRefPubMed Meisamy S, Bolan PJ, Baker EH, Bliss RL, Gulbahce E, Everson LI, et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in-vivo 1H MR spectroscopy—a pilot study at 4T. Radiology. 2004;233:424–31.CrossRefPubMed
24.
Zurück zum Zitat Krouwer HG, Kim TA, Rand SD, Prost RW, Haughton VM, Ho KC, et al. Singlevoxel proton MR spectroscopy of non neoplastic brain lesions suggestive of a neoplasm. Am J Neuroradiol. 1998;19:1695–703.PubMed Krouwer HG, Kim TA, Rand SD, Prost RW, Haughton VM, Ho KC, et al. Singlevoxel proton MR spectroscopy of non neoplastic brain lesions suggestive of a neoplasm. Am J Neuroradiol. 1998;19:1695–703.PubMed
25.
Zurück zum Zitat Venkatesh SK, Gupta RK, Pal L, Husain N, Husain M. Spectroscopic increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brain. J Magn Reson Imaging. 2001;14:8–15.CrossRefPubMed Venkatesh SK, Gupta RK, Pal L, Husain N, Husain M. Spectroscopic increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brain. J Magn Reson Imaging. 2001;14:8–15.CrossRefPubMed
26.
Zurück zum Zitat Fayad LM, Bluemke DA, McCarthy EF, Weber KL, Barker PB, Jacobs MA. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging. 2006;23(1):23–8.CrossRefPubMed Fayad LM, Bluemke DA, McCarthy EF, Weber KL, Barker PB, Jacobs MA. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging. 2006;23(1):23–8.CrossRefPubMed
27.
Zurück zum Zitat Maheshwari SR, Mukherji SK, Neelon B, Schiro S, Fatterpekar GM, Stone JA, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in-vitro MR spectroscopy. Am J Neuroradiol. 2000;21(10):1930–5.PubMed Maheshwari SR, Mukherji SK, Neelon B, Schiro S, Fatterpekar GM, Stone JA, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in-vitro MR spectroscopy. Am J Neuroradiol. 2000;21(10):1930–5.PubMed
28.
Zurück zum Zitat Fayad LM, Barker PB, Jacobs MA, Eng J, Weber KL, Kulesza P, et al. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. Am J Roentgenol. 2007;188:1513–20.CrossRef Fayad LM, Barker PB, Jacobs MA, Eng J, Weber KL, Kulesza P, et al. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. Am J Roentgenol. 2007;188:1513–20.CrossRef
29.
Zurück zum Zitat Lee CW, Lee JH, Kim DH, Min HS, Park BK, Cho HS, et al. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification. Clin Imaging. 2010;34:47–52.CrossRefPubMed Lee CW, Lee JH, Kim DH, Min HS, Park BK, Cho HS, et al. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification. Clin Imaging. 2010;34:47–52.CrossRefPubMed
30.
Zurück zum Zitat Costa FM, Vianna EM, Domingues RC, Setti M, Meohas W, Rezende JF, et al. Proton magnetic resonance spectroscopy and perfusion magnetic resonance imaging in the evaluation of musculoskeletal tumors. Radiol Bras. 2009;42(4):215–23.CrossRef Costa FM, Vianna EM, Domingues RC, Setti M, Meohas W, Rezende JF, et al. Proton magnetic resonance spectroscopy and perfusion magnetic resonance imaging in the evaluation of musculoskeletal tumors. Radiol Bras. 2009;42(4):215–23.CrossRef
31.
Zurück zum Zitat Russo F, Mazzetti S, Grignani G, De Rosa G, Aglietta M, Anselmetti GC, et al. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy. Eur Radiol. 2012;22:1131–9.CrossRefPubMed Russo F, Mazzetti S, Grignani G, De Rosa G, Aglietta M, Anselmetti GC, et al. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy. Eur Radiol. 2012;22:1131–9.CrossRefPubMed
32.
Zurück zum Zitat Fayad LM, Barker PB, Bluemke DA. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol. 2007;11(3):240–5.CrossRefPubMed Fayad LM, Barker PB, Bluemke DA. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy. Semin Musculoskelet Radiol. 2007;11(3):240–5.CrossRefPubMed
Metadaten
Titel
Characterisation of musculoskeletal tumours by multivoxel proton MR spectroscopy
verfasst von
Ruchi S. Patni
Deb K. Boruah
Shantiranjan Sanyal
Bidyut B. Gogoi
Maninder Patni
Rosy Khandelia
Nripen Gogoi
Publikationsdatum
11.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 4/2017
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-017-2573-1

Weitere Artikel der Ausgabe 4/2017

Skeletal Radiology 4/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.